Premium
Successful treatment of pemphigus foliaceus in a Berrichon du Cher ram with methylprednisolone acetate
Author(s) -
Lambacher Bianca,
Schoiswohl Julia,
Brunthaler Rene,
Wittek Thomas,
KrametterFrötscher Reinhild
Publication year - 2017
Publication title -
veterinary dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.744
H-Index - 60
eISSN - 1365-3164
pISSN - 0959-4493
DOI - 10.1111/vde.12442
Subject(s) - pemphigus foliaceus , methylprednisolone , medicine , pemphigus , dermatology , leukopenia , gastroenterology , toxicity , immunology , antibody , autoantibody
Background Pemphigus foliaceus is a severe, autoimmune blistering skin disease, which is described in humans and some animal species. In small ruminants pemphigus foliaceus has rarely been described and, to the best of the authors’ knowledge, little information is available about successful treatment in sheep. Aim This case report describes a Berrichon du Cher ram with the presumed diagnosis of pemphigus foliaceus. Methods The ram was treated with methylprednisolone acetate 40 mg at a dosage of 2.5 mg/kg in one subcuticular injection at four week intervals over a one year period, with regular observation of clinical parameters. Four months after treatment was initiated the haematological parameters showed lymphopenia and leukopenia; some enzyme activities were substantially increased. Results The ram's dermatological condition improved to the point of complete healing of the affected skin. The ram was discharged in good condition. No adverse effects, except an elevation of some enzymes associated with liver function, were observed. At postmortem examination moderate fatty liver syndrome was the only abnormality found. Conclusions and clinical importance This case report demonstrated that long term therapy with methylprednisolone acetate in a sheep with pemphigus foliaceus did not have a negative effect on clinical parameters. Nevertheless, due to the extended statutory withdrawal period resulting from the regular administration of glucocorticoids, such a therapeutic option must be critically assessed in food producing animals.